|
|
 |
|
Viewing report
|
|
|
|
China Vaccine 2008
General Biologic, Dec 2007, Pages: 72
The purpose and scope of this report
Executive summary
I History of vaccines in China
Early history
People's Republic of China
1950s -1978
1978 - Present
II Vaccine products
Whole-pathogen vaccines
Live-attenuated vaccines
Inactivated vaccines
Toxoid vaccines
Subunit vaccines
III China's human-use vaccine market
Large population
Growing economic strength and consumer base
Enhanced awareness of disease prevention
Market estimation methodology
Product presentation
Market estimation from vaccine batch approvals
Market estimation from China's immunization statistics
China's current and future vaccine market
Type I (NIP) market
Type II (Non-NIP) market - Children
- Chickenpox
- Measles, Mumps and Rubella (MMR)
- Haemophilus influenzae Type b (Hib)
- Diphtheria, Tetanus, and Pertussis (DTaP)
- Hepatitis A
- Pneumonia
Type II (Non-NIP) market - Adults
- Hepatitis A
- Hepatitis B
Type II (Non-NIP) market - Adults & children
- Rabies
- Influenza - children
- Influenza - adults
Vaccine pricing
Looking forward: China's future human-use vaccine market
- Extension of the NIP
- China encounters a fourth baby boom
- Adults are potential consumers
- Expanded range of vaccines on the market
IV China's human-use vaccines
Type I (NIP) vaccines
Type I (NIP) vaccine market players
Type I (NIP) vaccines
- BCG vaccine
- DTP and DT vaccine
- Hepatitis B vaccine
- Measles vaccine
- Oral Polio Vaccine (OPV)
China's Type II (Non-NIP), charged vaccines
Type II vaccine market players
The main Type II (charged) vaccines
- DTaP vaccine
- Hepatitis A vaccine
- Hepatitis B vaccine
- Combined hepatitis A and B vaccine
- Haemophilus influenzae Type b (Hib) vaccine
- Influenza vaccine
- Measles, Mumps and Rubella (MMR) combined vaccine
- Polyvalent pneumococcal polysaccharide vaccine
- Rabies vaccine
- Varicella (chickenpox) vaccine
V Vaccine R&D in China
Novel prophylactic vaccines
- HIV vaccines
- H5N1 bird flu
- Hepatitis E vaccine
- SARS vaccine
Novel therapeutic vaccines
- Hepatitis B therapeutic vaccine
Foreign R&D presence in China
- Institut Pasteur de Shanghai - Chinese Academy of Sciences Bio-Bridge Science
VI Players and business models in China
Distributors and inoculation clinics
Institutes
Companies
Multinational companies
Domestic companies
- State-owned enterprise (SOE)
- Private companies
VII Vaccine policy and Chinese government
Intellectual property
- Central versus local interests
- Patent Laws and Regulations
Important government departments for vaccines
Important laws and regulations for vaccines
Import and export issues - drug import management regulations
Vaccine approval process
VIII Opportunities
Government
Companies
Prophylactic vaccines
Therapeutic vaccines
Opportunities for multinationals
IX Case Studies
China National Biotec Group
- Overview
- Vaccine business
- Product series
- S W O T
Appendix
Domestic vaccine players
Foreign vaccine players
Table of acronyms
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
China Vaccine Market Report, 2007-2009
China Vaccine Market Report, 2007-2009
Analysis of Animal Vaccine Market in China 2009
China Vaccine Industry Report, 2008-2009
China Vaccine Industry Report, 2008-2009
Research Report on China's foot-and-mouth disease Vaccine (FMD Vaccine) Industry, 2009
China Animal Vaccine Industry Report, 2006-2009
China Animal Vaccine Industry Report, 2006-2009
Research Report on China's Animal Vaccine Industry, 2009
China Company Research - Beijing Tiantan Biological Products Co., Ltd.
China Company Report -- Hualan Biological Engineering Inc
China Pharmaceuticals and Healthcare Report Q2 2008
|
|
|
|
